What is Fifth Disease?
What causes Fifth Disease?
Who gets Fifth Disease?
How does parvovirus B-19 cause disease?
What are the common findings?
How is Fifth Disease diagnosed?
How is Fifth Disease treated?
What are the complications?
How can Fifth Disease be prevented?
What research is being done?
by Hal B. Jenson, M.D.
Chief, Pediatric Infectious Diseases
University of Texas Health Science Center
San Antonio, TX
by Charles T. Leach, M.D.
Associate Professor of Pediatrics
University of Texas Health Science Center
San Antonio, TX
Fifth Disease, also known as "erythema infectiosum," is a mild, self-limited viral infection. It most commonly occurs in children, and is characterized primarily by fever and a distinctive rash, usually over the cheeks. This distinctive rash is responsible for another name occasionally used for this disease, "slapped-cheek disease."
Fifth Disease is caused by human parvovirus B19, a DNA virus in the parvovirus family of viruses. This is the only virus in this family that causes disease in humans.
Parvovirus B19 predominantly infects school children. Children generally acquire an infection during the school months, until May and June. Epidemics occur approximately every six years, and last approximately three years.
Parvovirus B19 is transmitted from person-to-person by direct contact or by contaminated secretions of the nose and the mouth. Parvovirus B19 infects the lining of the nose and the upper respiratory tract. Then, it is spread through the blood throughout the body, which causes the rash. The virus also infects the bone marrow cells that are responsible for producing new red blood cells. This particular characteristic may result in complications in those persons who have an underlying anemia or other blood disorder.
Fifth Disease can be divided into four phases: 1) the incubation phase, 2) the prodromal phase, 3) the rash phase, and 4) the recovery phase. The incubation phase typically lasts 8 to 12 days after exposure to the virus and does not have any symptoms. During the prodromal phase, the symptoms are mild and include a headache, a low-grade fever, fatigue, and a sore throat. These symptoms usually last for a few days and then resolve. The rash that develops produces an intense rose-red color on both cheeks that does not involve the area around the mouth. This rash is often referred to as the "slapped cheek" rash because of its appearance. The rash usually lasts one to four days and then fades. On other parts of the body, a less prominent rash can occur at the same time or within one to two days. The chest, arms, and legs can develop a flat red rash that has a lace-like appearance.
Adults who get a parvovirus B19 infection are more likely than children to develop joint aches and pains. This typically develops at the time that the rash appears. The joint symptoms usually resolve within four months, but they may persist for a year or more.
The infection is usually diagnosed by the characteristic appearance of the rash in a child with a fever and no other symptoms. A blood test is available to confirm the infection; however, it usually is not necessary.
Specific treatment for Fifth Disease is not available. Antibiotics are not helpful because a virus causes Fifth Disease. Viruses cannot be treated with antibiotics. Fever and pain should be treated with acetaminophen or ibuprofen. The disease is usually mild with complete recovery.
Patients with underlying anemia may require a blood transfusion during the acute illness, but they then recover to their previous state of health.
Children who have underlying anemia are at risk for developing worse anemia with the parvovirus B19 infection. The virus infects the blood cells that produce red blood cells and causes a temporary decrease in the production of red blood cells. Some children require one or, occasionally, more transfusions. Usually, there is recovery within one to two weeks, with a return to normal blood counts within three to four weeks.
The parvovirus B19 infection in pregnant women can result in transmission of the virus to the fetus, and the bone marrow cells of the fetus are infected. This results in anemia in the fetus and leads to the condition known as "hydrops fetalis," which is associated with fetal heart failure and may cause fetal death and spontaneous abortion. However, even if a woman acquires the parvovirus B19 infection during pregnancy, chances for fetal survival are probably 90%. The virus does not cause birth defects or other problems if the fetus survives the period of the maternal infection.
A vaccine is not available for the human parvovirus B19 infection. Because of the widespread nature of the virus, there is no way to eliminate the risk of exposure. Healthy children with Fifth Disease can attend day care or school because they are most contagious before the rash, and are unlikely to be contagious after the onset of the rash.
Routine exclusion of pregnant women from the workplace or social events is not recommended. Pregnant women who find that they have been in close contact with children in the few days before the onset of the rash of Fifth Disease, or of children who had anemia from Fifth Disease, are at a low risk of infection and complications. Blood tests and fetal ultrasound can help assess the possibility of infection of the fetus.
Substantial research is currently being performed to develop a vaccine to prevent the human parvovirus B19 infection. If proved to be safe and effective, a vaccine could be administered to children early in life to prevent infection during childhood. The vaccine also could be administered during pregnancy to prevent the occasional fetal death that occurs from the parvovirus B19 infection.
About the Authors
Hal Jenson, M.D.
Dr. Jenson graduated from George Washington University School of Medicine in Washington, DC,
He also completed a residency in pediatrics at the Rainbow Babies and Children's Hospital of Case Western Reserve University in Cleveland, Ohio, and a fellowship in pediatric infectious diseases and epidemiology at Yale University School of Medicine.
Dr. Jenson has an active research program on the biology of Epstein-Barr virus and other human and non-human primate herpes viruses.
He is active in the general pediatric and infectious diseases teaching and clinical activities of his Department and Division, is a co-editor of Nelson Textbook of Pediatrics and of Pediatric Infectious Diseases: Principles and Practice, and authors the book Pocket Guide to Vaccination and Prophylaxis.
Charles T. Leach, M.D.
Dr. Leach received his medical degree at the University of Utah School of Medicine and completed his pediatrics residency as well as a fellowship in pediatric infectious diseases at UCLA.
He is currently Associate Professor and Director of Research in the Department of Pediatrics at the University of Texas Health Science Center at San Antonio.
Dr. Leach conducts scientific research in the areas of herpes virus infections, pediatric AIDS, and infectious diseases among residents of the Texas-Mexico border.
Copyright 2012 Hal B. Jenson, M.D., All Rights Reserved
The information contained in these topics is not intended nor implied to be a substitute for professional medical advice, it is provided for educational purposes only. You assume full responsibility for how you choose to use this information.
Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Talk with your healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.
By using this website, you accept the information provided herein "AS IS." Neither RemedyConnect nor the providers of the information contained herein will have any liability to you arising out of your use of the information contained herein or make any express or implied warranty regarding the accuracy, content, completeness, reliability, or efficacy of the information contained within this website.
RemedyConnect, Inc. has created this privacy statement in order to demonstrate our firm commitment to your privacy. The following discloses our information gathering and dissemination practices for this website: http://www.remedyconnect.com.
We do not acquire any more information about website visitors than is required by law or is otherwise necessary to provide a high level of service efficiently and securely. Our site's registration form requires users to give us contact information (e.g., their name and e-mail address) and demographic information (e.g., children's birth months, but not birth dates). We use customer contact information from the registration form to (1) send the user pertinent medical and parenting information and (2) allow your local health provider lists of who is registering on that provider's site as a parent/guardian, staff member, doctor, or visitor. Users may opt-out of receiving future mailings; see the choice/opt-out section below.
We use your IP address to help diagnose problems with our server and to administer our Website. Your IP address is used to help identify you and to gather broad demographic information.
Demographic and profile data is also collected at our site. We may use this data to tailor the visitor's experience at our site, showing them content that we think they might be interested in, and displaying the content according to their preferences.
Our site may use order forms to allow users to request information, products, and services.
We will respect your doctor's right to privacy. A doctor typically does not give his/her e-mail address to the parents/guardians of patients. We will not provide the e-mail addresses of doctor(s) in the local practice to users of their site without the doctor(s)' permission. Their site is restricted to use by whomever they wish, and they may deny access to their site to one or more prior users. In unusual cases, doctors may change their private site's access code and arrange for us to e-mail the new access code to approved users.
This site contains links to other sites. RemedyConnect.com is not responsible for the privacy practices or the content of such Websites. See Disclaimers.
We will provide individually-identifiable information about website users to third parties only if we are compelled to do so by order of a duly-empowered governmental authority, we have the express permission of the visitor, or it is necessary to process transactions and provide you services from our affiliates: Live Agent Answering Service, Digital Answering Service, Medical Answering Service and Pediatric Answering Service.
This site may make chat rooms, forums, message boards, and/or news groups available to its users. Please remember that any information that is disclosed in these areas becomes public information and you should exercise caution when deciding to disclose your personal information.
This site has security measures in place to protect the loss, misuse and alteration of the information under our control. For further information regarding our security, please contact us at email@example.com. If you have any concerns regarding the security of information, please do not provide any information to RemedyConnect, Inc. until you are comfortable with our security measures.
You may correct or update your User Registration information at any time, by visiting the User Registration section and providing your personal password that you set at registration. If need be, please email us at firstname.lastname@example.org.
Our site provides users the opportunity to opt-out of receiving e-mail communications from our partners or us, except communications approved by your doctor's practice office. To so opt-out, please email us at email@example.com. To be removed as a user, please email us at the same address. If need be, you may mail requests to us at RemedyConnect, Inc., 9200 E. Mineral Avenue, Suite 100, Centennial, CO 80112. Our telephone number is 303-793-0703.
If you have any questions about this privacy statement, the practices of this site, or your dealings with this Website, you can contact us by email at firstname.lastname@example.org or by mail at our address above.